RFI SENTINEL 3.0

Your Complete Guide to a $304M FDA Sentinel 3.0 Opportunity

The U.S. Food and Drug Administration (FDA) is launching Sentinel 3.0 — a $304 million, multi-award IDIQ contract that will redefine post-market safety surveillance of medical products. Building on the Sentinel Initiative first launched in 2008, Sentinel 3.0 is designed to unify systems across FDA centers and protect 100M+ patients through the power of AI, cloud technology, and advanced analytics.

Uncover detailed insights, including:

• Contract Overview: A $304 M ceiling, Multi-Award Tiered IDIQ.
• Modernization Objectives: To unify systems across FDA centers and protect 100M+ patients using AI, cloud technology, and advanced analytics.
• Key Scope of Work: Building a FedRAMP-authorized cloud Data Hub, developing an AI/ML-enabled Data Platform, integrating diverse data sources (claims, EHR, etc.), and delivering Scientific Support Services.

Download Now to access comprehensive requirements, evaluation insights, and proven strategies to position your business for success in this critical public health opportunity.